ScreenerHero

ACEAscelia Pharma AB (publ)

STO · SE · Healthcare · Biotechnology · ascelia.com
0.6100SEK+3.39%Mkt Cap: 7.79M $P/E: —

Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden. It develops Orviglance, a novel non-gadolinium diagnostic drug, wh…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap7.79M $
Enterprise Value4.32M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-7.29M $
Revenue/Share—
Last Price0.6100 SEK
Fiscal Year EndDec 2019
MR QuarterJun 2026
Employees—
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0010573113
Valuation
P/E (Trailing)—
P/E (Forward)-5.08
PEG—
EV/EBITDA-0.76
EV/Revenue—
P/S—
P/B0.92
EPS (TTM)-0.57
EPS (Forward)-0.12
52W Range
0.45503% of range5.130
52W High5.130 SEK
52W Low0.4550 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-76.66%
ROA-68.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.91M $
CapEx (TTM)5.45K $
FCF Margin—
FCF Yield-53.62%
Net Debt-3.59M $
Net Debt/EBITDA0.63
Balance Sheet
Debt/Equity0.01
Current Ratio4.11
Quick Ratio4.01
Book Value/Sh0.6620 SEK
Cash/Share0.2800 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.400 SEK
Upside (mean)+293.4%
Target Range1.000 SEK – 3.700 SEK
SEK1.000+293.4% to meanSEK3.700
# Analysts4
Ownership
Shares Out.133.54M
Float125.70M
Insiders13.35%
Institutions21.63%
Technical
SMA 501.252 (-51.3%)
SMA 2002.551 (-76.1%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)1.73M
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)36.1
MACD-0.1598
MACD Signal-0.2285
MACD Hist.+0.0687
BB Upper0.6334 SEK
BB Middle0.5594 SEK
BB Lower0.4853 SEK
BB Width26.47%
ATR (14)0.0820 SEK
Vol Ratio (20d)1.07x